Tambra Investments, INC.
Tambra Investments, INC. was paid $8K by Medicaid between Jan 2018 and Jul 2023, across 1 billing code. Its largest line is G0249, Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests — 100% of everything it billed.
WARREN, MI 48091
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 393 | $2K | |
| 2019 | 349 | $2K | |
| 2020 | 225 | $860.44 | |
| 2021 | 190 | $1K | |
| 2022 | 101 | $669.44 | |
| 2023 | 54 | $687.96 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 100% | 1,312 | 1,196 | $8K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Geisinger Pharmacy LLC | Danville, PA | $26.68M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.